{"entity":{"id":"veru","kind":"company","name":"Veru","aka":["Veru Inc.","Veru Pharma"],"tldr":"Veru is a Miami company whose oncology programmes were the selective androgen receptor modulator enobosarm for AR-positive, ER-positive breast cancer and the microtubule disruptor sabizabulin for prostate cancer, which was halted in 2022.","summary":"Veru Inc., listed on Nasdaq, moved from sexual health products into oncology and metabolic disease. Sabizabulin, an oral microtubule disruptor, was tested in metastatic castration-resistant prostate cancer (VERACITY) until the trial was stopped in 2022 and then, controversially, in COVID-19. Enobosarm, a selective androgen receptor modulator, was studied in androgen receptor-positive, oestrogen receptor-positive metastatic breast cancer (ARTEST, ENABLAR-2) before the company redirected it to preserving muscle during weight-loss therapy. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://verupharma.com"},{"label":"ClinicalTrials.gov: trials led by Veru","url":"https://clinicaltrials.gov/search?lead=Veru"},{"label":"Wikipedia","url":"https://en.wikipedia.org/wiki/Veru_Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["breast-hr-positive","prostate"],"sections":["hormonal"],"technologies":[],"targets":["androgen-receptor"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Miami, FL","country":"US","companyType":"biotech","website":"https://verupharma.com","stage":"public","investors":[],"funding":[]},"route":"/companies/veru/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"section":[{"id":"hormonal","kind":"section","name":"Hormonal Therapy","route":"/fronts/hormonal/"}],"target":[{"id":"androgen-receptor","kind":"target","name":"Androgen receptor","route":"/targets/androgen-receptor/"}]}}